Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Technology and Innovation

MedTech Town Hall

Panel Discussion: Innovative Technology Headwinds and Tailwinds

Tuesday, March 11, 2025
8:32 AM – 8:50 AM ET

    Panel Moderator(s)

  • Dorothy B. Abel, BSBME

    Partner
    Abel and Wolf Consulting
    Santa Rosa, California, United States

    Disclosure information not submitted.

  • Ron Waksman, MD, MSCAI

    Director, Cardiovascular Research and Advanced Education
    MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
    Washington, District of Columbia, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • Yuval Binur, PhD

    Managing Partner
    Arsuf Global Partners
    NEW YORK, New York, United States

    Disclosure information not submitted.

  • Chip Hance, BS, MBA

    CEO
    Regatta Medical
    Bannockburn, Illinois, United States

    Disclosure information not submitted.

  • Mitchell Krucoff, MD, FACC, FAHA, FSCAI

    Professor Medicine/Cardiology
    Duke University Medical Center/Duke Clinical Research Institute
    Durham, North Carolina, United States

    Disclosure information not submitted.

  • Katherine Kumar, PhD, RAC

    Sr. EVP
    4C Medical Technologies, Inc.
    Minnetonka, Minnesota, United States

    Disclosure information not submitted.

  • William H. Maisel, MD, MPH

    VP & Senior Medical Officer
    Intuitive Surgical
    Silver Spring, Maryland, United States

    Disclosure information not submitted.

  • Stanton J. Rowe, PhD

    CEO
    NXT Biomedical
    Irvine, California, United States

    Disclosure(s): Gradient Denervation: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Nidus Biomedical: Employee (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Symbiosis Ltd: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vivifi Medical: Director (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-privately held company (Ongoing)

  • Mark A. Turco, MD

    CEO & President
    JC Medical and Genesis MedTech
    Providence, Rhode Island, United States

    Disclosure information not submitted.

Disclosure(s):
Andrew Farb, MD: No financial relationships to disclose
April Marrone, PhD, MBA: No financial relationships to disclose